Ketek Linked to Liver Damage
January 2006: Reports of three patients who experienced serious liver toxicity, including one death, following their use of Ketek. Due to this report and as a result of an FDA investigation, new safety information has been added to the product's labeling.
Background:
Ketek, also known as telithromycin and manufactured by Sanofi-Aventis, is an antibiotic used to treat common respiratory infections including chronic bronchitis and acute bacterial sinusitis. Ketek was originally denied FDA approval in 2001 and 2003 due to the lack of safety information, but was finally approved in 2004. In January 2006, Annals of Internal Medicine published an article reporting three patients who experienced serious liver toxicity following administration of Ketek. Based on these findings, the FDA began sending out recommendations to healthcare providers and patients that may have been adversely affected by the use of Ketek.
Where can I find additional information:
What you can do:
If you have experienced any serious side effects associated with your use of Ketek, you are urged to seek medical attention. It may also be important to contact an attorney who can help you protect your potential legal claim. If you would like more information, or would just like to talk with a lawyer experienced in this litigation, please call attorney Stacy Hauer at 1.800.755.0098 for a free consultation or click here to fill out an online free case review.
|
